BioScrip Aktie - Fundamentalanalyse - Dividendenrendite KGV

BioScrip (ISIN: US09069N1081, WKN: A0DQLD) Kursdatum: 18.06.2018 Kurs: 2,700 USD
Beschreibung Daten
Symbol BIOS
Marktkapitalisierung 334.235.712,00 USD
Land Vereinigte Staaten von Amerika
Indizes NASDAQ Comp.
Sektor Gesundheitswesen
Rohdaten nach US GAAP in Millionen USD
Aktiensplits
Internet www.bioscrip.com
Letztes Bilanz Update 26.03.2018

Fundamentaldaten

Fundamental Verhältnisse errechnet am: 18.06.2018
KFCV KCV DIV Rendite GKR EKQ KGV KUV KBV
-35,40 -438,05 0,00% -12,32 -14,05 -4,50 0,41 -3,94

Firmenbeschreibung

BioScrip, Inc. provides infusion solutions in the United States. It engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. The company is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. It also offers home nursing products and services to patients suffering from chronic and acute medical conditions. The company offers its services at patient\'s homes, outpatient clinics, nursing facilities, physician\'s offices, and ambulatory infusion centers. It markets and sells its products and services through sales and marketing representatives, and payor relationships. The company was founded in 1993 and is based in Denver, Colorado.

Die Finanzoo GmbH übernimmt keine Haftung für die Richtigkeit der Angaben! Alle Angaben sind ohne Gewähr. Quellen: www.bundesanzeiger.de, www.sec.gov, www.bioscrip.com